晶体液联合血浆液体复苏对低白蛋白血症脓毒症患者预后的影响
该回顾性研究纳入东台市人民医院重症医学科2017年1月至2022年12月收治的164例低白蛋白血症脓毒症患者,按入科时液体复苏方案分为单用晶体液组(60例)和晶体液联合血浆组(104例)。主要终点28天死亡率两组无显著差异[55.0%(33/60)vs. 42.3%(44/104),P>0.05]。联合组第3天抗凝血酶Ⅲ(AT-Ⅲ)水平改善程度显著优于单用组[(79.80±17.95)% vs.(66.67±18.69)%,P<0.01]。白蛋白<25 g/L患者28天死亡率显著高于25-30 g/L和>30 g/L患者[63.1%(41/65)vs. 36.2%(25/69)、36.7%(11/30),均P<0.05]。
要点
- 低白蛋白血症脓毒症患者中,晶体液联合血浆组与单用晶体液组28天死亡率无显著差异[55.0%(33/60)vs. 42.3%(44/104),P>0.05]。
- 联合组第3天AT-Ⅲ水平改善程度显著优于单用组[(79.80±17.95)% vs.(66.67±18.69)%,P<0.01]。
- 白蛋白<25 g/L患者28天死亡率63.1%(41/65),显著高于25-30 g/L的36.2%(25/69)和>30 g/L的36.7%(11/30),均P<0.05。
- 两组28天累积生存率无显著差异(Log-Rank:χ²=2.067,P=0.151)。
- 两组复苏后乳酸和白蛋白水平均显著改善,但改善程度组间无显著差异。
适用人群与场景
- 东台市人民医院重症医学科2017年1月至2022年12月收治的低白蛋白血症脓毒症患者,共164例,其中单用晶体液组60例、晶体液联合血浆组104例。
处置流程与药物剂量
- 按入科时液体复苏方案分为单用晶体液组(60例)和晶体液联合血浆组(104例),具体晶体液种类、血浆输注剂量及频次原文未写明。
研究设计与关键结果
- 回顾性研究,纳入164例低白蛋白血症脓毒症患者,单用晶体液组60例、晶体液联合血浆组104例;两组年龄、性别、APACHEⅡ、SOFA及复苏前PLT、PT、APTT、D-二聚体、AT-Ⅲ、INR、FDP、乳酸、白蛋白水平均无显著差异。
- 联合组第3天PT和AT-Ⅲ较复苏前显著改善,且第3天AT-Ⅲ改善程度显著优于单用组[(79.80±17.95)% vs.(66.67±18.69)%,P<0.01]。
- 两组复苏后乳酸和白蛋白水平均显著改善,但改善程度组间无显著差异。
- 28天死亡率单用组55.0%(33/60)vs. 联合组42.3%(44/104),P>0.05;白蛋白<25 g/L组63.1%(41/65)显著高于25-30 g/L组36.2%(25/69)和>30 g/L组36.7%(11/30),均P<0.05。
- Kaplan-Meier生存曲线显示两组28天累积生存率无显著差异(Log-Rank:χ²=2.067,P=0.151);中位生存白蛋白单用组27.1 g/L(95%CI 24.203-29.997),联合组28.7 g/L(95%CI 26.065-31.335)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,晶体液联合血浆可改善低白蛋白血症脓毒症患者的外源性凝血功能障碍,但未改善28天死亡结局;初始白蛋白水平越高,死亡率越低。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the difference in efficacy of two fluid resuscitation regimens, crystalloid alone versus crystalloid combined with plasma infusion, on the prognosis of septic patients with hypoalbuminemia.
METHODS: A retrospective study was conducted. Septic patients with hypoalbuminemia admitted to the department of critical care medicine of Dongtai People's Hospital from January 2017 to December 2022 were selected as study subjects. Patients were divided into single group (crystalloid alone) and combined group (crystalloid combined with plasma) according to the fluid resuscitation regimen at the time of admission. General information, as well as coagulation indices before resuscitation (on day 1) and day 3 of resuscitation were collected. The primary study endpoint was 28-day mortality. The single and combined groups were stratified according to albumin level at resuscitation (< 25 g/L, 25-30 g/L, and > 30 g/L) to compare the differences in 28-day mortality among patients with different albumin levels. Kaplan-Meier survival curves of patients' 28-day prognosis were plotted.
RESULTS: A total of 164 septic patients with hypoalbuminemia were included, including 60 patients in the single group and 104 patients in the combined group. (1) There were no significantly differences in age, gender, acute physiology and chronic health evaluation II (APACHE II), sequential organ failure assessment (SOFA), as well as pre-resuscitation platelet count (PLT), prothrombin time (PT), activated partial thromboplastin time (APTT), D-dimer, antithrombin- III (AT- III), international normalized ratio (INR), fibrin degradation product (FDP), serum lactic acid (Lac), and albumin level between the two groups, indicating comparability. (2) The levels of PT and AT- III in the combined group improved significantly on day 3 compared to before resuscitation, and the level of AT- III in the combined group improved more significantly on day 3 compared to the single group [(79.80±17.95)% vs. (66.67±18.69)%, P < 0.01]. Lac and albumin levels improved significantly after resuscitation in both the single and combined groups, but there were no significantly differences in the degree of improvement between the two groups. (3) There was no significantly difference in the 28-day mortality between the single group and the combined group [55.0% (33/60) vs. 42.3% (44/104), P > 0.05]. The 28-day mortality of patients with albumin < 25 g/L was significantly higher than that with albumin 25-30 g/L and > 30 g/L [63.1% (41/65) vs. 36.2% (25/69), 36.7% (11/30), both P < 0.05]. (4) Kaplan-Meier survival curve analysis showed that there was no significantly difference in 28-day cumulative survival rate between the single group and the combined group (Log-Rank: χ 2 = 2.067,P = 0.151). The median survival rate of albumin was 27.1 g/L [95% confidence interval (95%CI) was 24.203-29.997] in the single group and 28.7 g/L (95%CI was 26.065-31.335) in the combined group.
CONCLUSIONS: Fluid resuscitation with crystalloid combined with plasma improves exogenous coagulation dysfunction in septic patients with hypoalbuminemia, but does not improve 28-day mortality outcome. The higher the initial albumin level in septic patients, the lower the mortality.
参考来源
- Xu W, Li J. [Effect of fluid resuscitation with crystalloid combined with plasma on the prognosis of septic patients with hypoalbuminemia]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 39238404. doi:10.3760/cma.j.cn121430-20231012-00864
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。